To further adjust the effects of glucose metabolism and liver function, we undertook logistic regression analysis and confirmed that polymorphisms of IFNL3 rs12971396 (as a representative locus) were associated with dyslipidemia in people with obesity. Here, IFNL3 is linked to metabolic syndrome.